239 related articles for article (PubMed ID: 2536358)
1. The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis.
Hendricks RL; Epstein RJ; Tumpey T
Invest Ophthalmol Vis Sci; 1989 Jan; 30(1):105-15. PubMed ID: 2536358
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis.
Hendricks RL; Tao MS; Glorioso JC
J Immunol; 1989 Jan; 142(1):263-9. PubMed ID: 2909617
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions.
Ksander BR; Hendricks RL
Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):1986-93. PubMed ID: 2824400
[TBL] [Abstract][Full Text] [Related]
4. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
Hendricks RL; Tumpey TM
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289
[TBL] [Abstract][Full Text] [Related]
5. Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity.
Lausch RN; Kleinschradt WR; Monteiro C; Kayes SG; Oakes JE
Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1509-15. PubMed ID: 2997073
[TBL] [Abstract][Full Text] [Related]
6. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
Hendricks RL; Janowicz M; Tumpey TM
J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
[TBL] [Abstract][Full Text] [Related]
7. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice.
McLeish W; Rubsamen P; Atherton SS; Streilein JW
Reg Immunol; 1989; 2(4):236-43. PubMed ID: 2561960
[TBL] [Abstract][Full Text] [Related]
8. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH
J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice.
Hendricks RL; Tumpey TM; Finnegan A
J Immunol; 1992 Nov; 149(9):3023-8. PubMed ID: 1401927
[TBL] [Abstract][Full Text] [Related]
10. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection.
Martin S; Rouse BT
J Immunol; 1987 May; 138(10):3431-7. PubMed ID: 3033075
[TBL] [Abstract][Full Text] [Related]
11. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis.
Russell RG; Nasisse MP; Larsen HS; Rouse BT
Invest Ophthalmol Vis Sci; 1984 Aug; 25(8):938-44. PubMed ID: 6611324
[TBL] [Abstract][Full Text] [Related]
12. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
Schmid DS; Rouse BT
J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
[TBL] [Abstract][Full Text] [Related]
13. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease.
Hendricks RL; Weber PC; Taylor JL; Koumbis A; Tumpey TM; Glorioso JC
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1601-10. PubMed ID: 1649898
[TBL] [Abstract][Full Text] [Related]
14. Effects of cyclosporine A on clinical and immunological parameters in herpes simplex keratitis.
Meyers-Elliott RH; Chitjian PA; Billups CB
Invest Ophthalmol Vis Sci; 1987 Jul; 28(7):1170-80. PubMed ID: 3036742
[TBL] [Abstract][Full Text] [Related]
15. Induction of cell-mediated immunity in herpes simplex virus keratitis. Kinetics of lymphocyte transformation and the effect of antiviral antibody.
Meyers-Elliott RH; Chitjian PA
Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):920-9. PubMed ID: 6250986
[TBL] [Abstract][Full Text] [Related]
16. Superiority of antibody versus delayed hypersensitivity in clearance of HSV-1 from eye.
Lausch RN; Monteiro C; Kleinschrodt WR; Oakes JE
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):565-70. PubMed ID: 3030956
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
[TBL] [Abstract][Full Text] [Related]
18. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
19. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
Matoba AY; Peeler JS; Niederkorn JY
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
[TBL] [Abstract][Full Text] [Related]
20. The dichotomy between herpes simplex virus type 1-induced ocular pathology and systemic immunity.
Metzger EE; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1533-40. PubMed ID: 3040615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
